The Hyderabad-based Centre for Cellular and Molecular Biology (CCMB) recently announced the development of the country's first potential mRNA vaccine candidate to fight against SARS-CoV-2, stating that it has an advantage of flexibility which isn't with other vaccine platforms.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2Qwg4Pm
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» With mRNA vaccine, India will have flexibility against COVID-19: Scientist
https://ift.tt/0RfLM2b
No comments:
Post a Comment